URAL Sodium Bicarbonate / Sodium Citrate / Citric Acid / Tartaric Acid 1760mg / 630mg / 720mg / 890mg per sachet Effervescent Granule 4g x 1's
We recognize that purchasing medications can be a deeply personal matter. To respect your privacy, we ensure that all orders are packaged discreetly, with no indication of the contents on the packaging. This means that even our couriers remain unaware of the package contents.
Furthermore, we uphold strict confidentiality standards. We guarantee that your order information will never be disclosed to any third party. Your trust is paramount to us, and we are committed to safeguarding your privacy at every step of the process. Our dedication to discretion and confidentiality is part of our unwavering commitment to you, our valued customer.
Features
- Bicarbonate
- Citrate
- Citric Acid
- Tartaric Acid
Description
Indications/Uses
Dosage/Direction for Use
Children 6-12 years: 4 g in half a glass of cold water, 2-3 times daily, taken on an empty stomach after effervescence has subsided. Additional water (approximately ½ glass) should subsequently be ingested.
Contraindications
Caution is advised in overt and occult cardiac failure. Concomitant use of urinary alkalinizers and quinolone antibiotics should be avoided. Crystalluria may be more likely to occur in alkaline urine.
Special Precautions
Ural should be used cautiously in patients with cardiac failure, hypertension, impaired renal function, peripheral and pulmonary edema and preeclampsia.
The clinical condition of the patient should be evaluated and laboratory determinations (eg, serum electrolytes, acid-base balance) obtained periodically during Ural therapy, particularly in patients with renal disease.
Use in pregnancy: Studies regarding the effect of citrates on pregnancy have not been done.
Use in lactation: Caution should be exercised when administered to a nursing mother.
Use In Pregnancy & Lactation
Use in lactation: Caution should be exercised when administered to a nursing mother.
Adverse Reactions
Drug Interactions
Antacids: Concurrent use of antacids with citrates may result in systemic alkalosis. Concomitant administration of antacids with sodium citrate and sodium bicarbonate may promote the development of calcium stones in patients with uric acid stones and may also cause hypernatremia. Concurrent use of aluminum-containing antacids with citrate salts can increase aluminum absorption, possibly resulting in acute aluminum toxicity, especially in patients with renal insufficiency.
Quinolones: Citrates may reduce the solubility of ciprofloxacin, norfloxacin or ofloxacin in the urine. Patients should be observed for signs of crystalluria and nephrotoxicity.
Laxatives: Concurrent administration of citrates with laxatives may have an additive effect.